The Global Biotechnology Market Growth Accelerated By Advancement In Gene Therapy Technologies
![]() |
Biotechnology Market |
Biotechnology industry has provided solutions to several
human health issues by enabling development of innovative drugs and gene
therapy techniques. Advancements in gene therapy involve modification of genes
or genetic materials to treat or prevent the occurrence of diseases. This
technique holds potential to cure genetic conditions by replacing missing or
mutated genes. The rapid progress in gene editing tools like CRISPR has enabled
more precise genome targeting capabilities.
The global Biotechnology Market is estimated to be valued at
US$ 820.4 Bn in 2024 and is expected to exhibit a CAGR of 3.5% over the forecast period 2023 to 2030, as highlighted
in a new report published by Coherent Market Insights.
Market key trends:
The growing acceptance of gene therapy as a treatment option for various
medical conditions is one of the key drivers of the biotechnology market. Gene
therapy holds potential to cure genetic diseases like cystic fibrosis, cancer,
diabetes, and cardiovascular diseases by replacing faulty genes or adding new
genes. For instance, Luxturna was the first gene therapy approved by the US FDA
for treating an inherited retinal dystrophy. Advances in CRISPR gene editing
tools have enabled fast, affordable and more precise genome editing
capabilities compared to earlier generation tools. CRISPR is being explored for
developing therapies for various genetic disorders. Rapid advancements in gene
therapy techniques are expected to accelerate the clinical translation and
commercialization of novel treatment options, thereby fueling the growth of the
global biotechnology market over the forecast period.
Segment Analysis
The global biotechnology market is dominated by the healthcare biotechnology
segment. Healthcare biotechnology leverages biotechnology techniques and tools
to develop healthcare products like drugs, therapeutics, diagnostics etc. It is
dominating as healthcare needs are continuously rising across regions due to
the increasing population and prevalence of diseases. Within healthcare
biotechnology, major sub-segments include pharmaceutical biotechnology,
bioservices, bioinformatics, gene therapy among others. Pharmaceutical
biotechnology dominates owing to continuous drug development activities and
increasing dependence on biologics and biosimilars.
Key Takeaways
The global biotechnology
market analysis is expected to witness high growth over the forecast
period of 2023 to 2030. The global Biotechnology Market is estimated to be
valued at US$ 820.4 Bn in 2024 and is expected to exhibit a CAGR of 3.5% over
the forecast period 2023 to 2030.
Regional analysis:
North America currently dominates the global biotechnology market led by
developed biotechnology infrastructure and presence of major players in the US
and Canada. However, Asia Pacific is expected to be the fastest growing region
owing to increasing R&D investments, growing targeted population and
expanding biologics manufacturing capabilities in major countries like China
and India.
Key players:
Key players operating in the biotechnology market are Amgen, Biogen Inc.,
Pfizer Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc,
Novartis AG, Merck KGaA, Gilead Sciences, Inc., AbbVie Inc. Pfizer Inc.
currently leads the global biotechnology drug sales, followed by Novartis AG
while Roche dominated the sales of biotechnology drugs in Europe.
Get more insights on this topic: https://www.newswirestats.com/iotechnology-market-industry-insights-trendsbiotechnology-market-2023-2030/
Comments
Post a Comment